Precision Biologics
  • Home
  • Company
    • About Us
    • Contact Us
    • Board
    • Leadership
  • Clinical
    • Pipeline
    • Companion Diagnostics
    • Therapeutics
    • Clinical Trials
  • Science
    • Publications
      • Recent
      • Historical
    • Abstracts
    • Posters
    • Presentations
  • News and Events
Search
  • Home
  • Company
    • About Us
    • Contact Us
    • Board
    • Leadership
  • Clinical
    • Pipeline
    • Companion Diagnostics
    • Therapeutics
    • Clinical Trials
  • Science
    • Publications
      • Recent
      • Historical
    • Abstracts
    • Posters
    • Presentations
  • News and Events
  • Home
  • News and Events
  • News

News

09MarMarch 9, 2022

Dr. Philip M. Arlen gives Immunotherapy Section Opening Keynote at Festival of Biologics, San Diego, March 9, 2022

Strattmont Group2022-03-09T10:48:47-05:00

Dr. Philip M. Arlen gives Immunotherapy Section Opening Keynote at Festival of Biologics 2022, San...

Facebook Twitter LinkedIn
Read more...
28JanJanuary 28, 2022

Precision Biologics, Inc. appoints Dr. Joyson Karakunnel to the Board of Directors

Strattmont Group2022-01-28T10:26:20-05:00

Dr. Joyson Karakunnel joins the Board of Directors of Precision Biologics, Inc. as its newest...

Facebook Twitter LinkedIn
Read more...
08NovNovember 8, 2021

Dr. Philip M. Arlen gives scientific presentation at Biomarkers UK: In-Person, November 8, 2021, Manchester, UK

Strattmont Group2021-11-05T14:50:15-04:00

Dr. Philip M. Arlen gives scientific presentation at Biomarkers UK: In-Person, Day 1 – November...

Facebook Twitter LinkedIn
Read more...
29OctOctober 29, 2021

Phase II Clinical Trial NEO-201 in Combination with Pembrolizumab Detailed Study Information

Strattmont Group2021-10-28T11:57:03-04:00

The Phase 2 Clinical Trial with a safety lead in, combining Precision Biologics monoclonal antibody...

Facebook Twitter LinkedIn
Read more...
28OctOctober 28, 2021

Precision Biologics to Deliver two Oral Presentations on our Clinical and Scientific Programs at 6th Annual Neoantigen Based Therapies Summit, October 26-28th, Digital Event

Strattmont Group2021-10-28T15:47:15-04:00

Dr Massimo Fantini, Director of Research is Presenting the following Talk entitled : “Stability Tests...

Facebook Twitter LinkedIn
Read more...
14OctOctober 14, 2021

Precision Biologics Commences Phase 2 Clinical Trial using NEO-201 and Pembrolizumab as a 2nd line Therapy in Patients with Solid Tumors

Strattmont Group2021-10-14T11:22:55-04:00

Precision Biologics announces that a Phase 2 Clinical Trial, combining NEO-201 with Pembrolizumab, is recruiting...

Facebook Twitter LinkedIn
Read more...
21AprApril 21, 2021

Dr. Philip M. Arlen gives scientific presentation at the 4th Annual Europe Neoantigen Summit 20th-22nd April 2021

Strattmont Group2021-04-21T08:30:59-04:00

Dr. Philip M. Arlen gives scientific presentation at the 4th Annual Europe Neoantigen summit, Clinical...

Facebook Twitter LinkedIn
Read more...
25MarMarch 25, 2021

Dr. Philip M. Arlen gives scientific presentation at the Festival of Biologics, World Immunotherapy Congress, USA

Strattmont Group2021-03-26T10:04:55-04:00

Dr. Philip M. Arlen gives scientific presentation at the Festival of Biologics, World Immunotherapy Congress,...

Facebook Twitter LinkedIn
Read more...
01DecDecember 1, 2020

Dr. Philip M. Arlen gives scientific presentation at World Vaccine & Immunotherapy Congress West Coast 2020, December 1 – 3, 2020

Strattmont Group2020-12-01T10:51:12-05:00

Dr. Philip M. Arlen gives scientific presentation at World Vaccine & Immunotherapy Congress West Coast...

Facebook Twitter LinkedIn
Read more...
03NovNovember 3, 2020

Dr. Philip M. Arlen gives scientific presentation in 5th Annual Neoantigen Based Therapies Summit 2020

Strattmont Group2020-11-16T12:20:03-05:00

Dr. Philip M. Arlen gives scientific presentation in 5th Annual Neoantigen Based Therapies Summit, entitled...

Facebook Twitter LinkedIn
Read more...
  Prev1…456…8Next  

Featured News

Precision Biologics, Inc. CEO to present at the online Antibody-Drug Conjugates MicroSummit conference, March 17th, 2026.
March 12, 2026
Precision Biologics featured in Pharma Device News article March 8, 2026
March 8, 2026
Precision Biologics, Inc. CEO Philip M. Arlen, MD, to give presentation on monoclonal antibodies against tumor-specific targets at Festival of Biologics USA, San Diego Convention Center, San Diego, CA, March 4-5, 2026
March 2, 2026
Want To Find Out More?

CONTACT INFO

301-500-8646

4922 Fairmont Avenue, Suite 320
Bethesda, MD 20814

COMPANY

Board
About Us
Contact Us
News and Events

CLINICAL

Pipeline
Diagnostics
Therapeutics
Clinical Trials

SCIENCE

Recent Publications
Publications – Historical
Abstracts
Posters
Presentations

© Copyright 2019-2025. Precision Biologics. All Rights Reserved.
Website Development By Strattmont Group